| Product Name | Linagliptin |
| Appearance | White Powder |
| Specification | 99% |
| Shelf Life | 2 Years |
Linagliptin
was approved by the FDA on May 2, 2011, it is used in combination with diet and exercise to improve the control of blood sugar levels in people with type 2 diabetes. Linagliptin improves glycemic control in patients by inhibiting dipeptidyl peptidase-4 (DPP-4).
Linagliptin is a selective DPP-4 inhibitor that inhibits the activity of the enzyme by reversibly binding to DPP-4, delays the degradation of GLP-1, enhances the activity of GLP-1, and reduces circulating glucose The level of hormones, thereby regulating the blood sugar levels of patients with type 2 diabetes.
1. Customs Clearance
1) By Express:
Normally there
is no specical need for the recipient to clear the customs. If the customs has an objection, our rich
experienced and professional group will help you clear the customs.